Clinical trial · Observational
Multi-center Validation of a Deep Learning Based Bowel Preparation Evaluation System
Validation of a Deep Learning Based Bowel Preparation Evaluation System: A Prospective, Multi-center, Cross-sectional Study
NCT04591145CI-TRIAL-00047760unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A deep learning based system to calculate the proportion of Boston Bowel Prep Scale (BBPS) score of 0-1 during withdrawal phase has been constructed previously. This multi-center study is going to perform a prospective observational study to validate the threshold of the adequate proportion.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adenoma | Adenoma | ONTOLOGY_EXACT | 0.98 |
| Bowel Preparation | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Observational group | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational group
- description
- Patients received bowel preparation and colonoscopy. The withdrawal phase video was saved and their lesions detection was record.
- interventionNames
- Other: Observational group
Primary outcomes (2)
- measure
- Cleanliness assessment of different intestinal segment in the artificial intelligence system
- timeFrame
- 3 Months
- description
- The Artificial intelligence evaluates the Boston Bowel Preparation score of the ascending colon, transverse colon and descending colon in real-time, and calculates the proportion of 0-1 Score
- measure
- Adenoma detection rate
- timeFrame
- 3 Months
- description
- The numerator is the number of cases of adenomas detected by colonoscopy, and the denominator is the total number of cases of patients undergoing colonoscopy.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male or female aged 18 years or above; * Ability to read, understand and sign informed consent forms; * The researchers believe that the subjects can understand the process of the clinical study and are willing and able to complete all the study procedures and follow-up visits to cooperate with the study procedures. Exclusion Criteria: * Patients with contraindications to colonoscopy (obstruction or perforation, severe acute inflammatory bowel disease, toxic megacolon, severe heart failure, severe heart failure, etc.); * Patients with galactosemia; * Pregnant or lactating women; * Patients used lactulose, a stimulant, or laxative within 7 days; * Patients refused to sign informed consent forms.
References
Publications (0)
Data not yet available
No reference posted for this study.